On the interface of aging, cancer, and neurodegeneration with SIRT6 and L1 retrotransposon protein interaction network
Ageing Research Reviews · 2024
DOI: 10.1016/j.arr.2024.102496 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Ageing Research Reviews, 2024. Verfasst von Jarmila Nahálková. Beteiligte Einrichtung: Biochemistry, Molecular, and Cell Biology Unit, Biochemworld co., Snickar-Anders väg 17, Skyttorp, Uppsala County 74394, Sweden. Electronic address: …. Hauptthemen laut MEDLINE: Sirtuins, Aging, Neoplasms, Protein Interaction Maps. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 149 Literaturangaben.
Abstract (Originalsprache)
Roles of the sirtuins in aging and longevity appear related to their evolutionarily conserved functions as retroviral-restriction factors. Retrotransposons also promote the aging process, which can be reversed by the inhibition of their activity. SIRT6 can functionally limit the mutation activity of LINE-1 (L1), a retrotransposon causing cancerogenesis-linked mutations accumulating during aging. Here, an overview of the molecular mechanisms of the controlling effects was created by the pathway enrichment and gene function prediction analysis of a protein interaction network of SIRT6 and L1 retrotransposon proteins L1 ORF1p, and L1 ORF2p. The L1-SIRT6 interaction network is enriched in pathways and nodes associated with RNA quality control, DNA damage response, tumor-related and retrotransposon activity-suppressing functions. The analysis also highlighted sumoylation, which controls protein-protein interactions, subcellular localization, and other post-translational modifications; DNA IR Damage and Cellular Response via ATR, and Hallmark Myc Targets V1, which scores are a measure of tumor aggressiveness. The protein node prioritization analysis emphasized the functions of tumor suppressors p53, PARP1, BRCA1, and BRCA2 having L1 retrotransposon limiting activity; tumor promoters EIF4A3, HNRNPA1, HNRNPH1, DDX5; and antiviral innate immunity regulators DDX39A and DDX23. The outline of the regulatory mechanisms involved in L1 retrotransposition with a focus on the prioritized nodes is here demonstrated in detail. Furthermore, a model establishing functional links between HIV infection, L1 retrotransposition, SIRT6, and cancer development is also presented. Finally, L1-SIRT6 subnetwork SIRT6-PARP1-BRCA1/BRCA2-TRIM28-PIN1-p53 was constructed, where all nodes possess L1 retrotransposon activity-limiting activity and together represent candidates for multitarget control.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Biochemistry, Molecular, and Cell Biology Unit, Biochemworld co., Snickar-Anders väg 17, Skyttorp, Uppsala County 74394, Sweden. Electronic address: jarmila.nahalkova@biochemworld.net.
Zitieren
APA
Nahálková, J. (2024). On the interface of aging, cancer, and neurodegeneration with SIRT6 and L1 retrotransposon protein interaction network. Ageing Research Reviews. https://doi.org/10.1016/j.arr.2024.102496
Vancouver
Nahálková J. On the interface of aging, cancer, and neurodegeneration with SIRT6 and L1 retrotransposon protein interaction network. Ageing Research Reviews. 2024. doi:10.1016/j.arr.2024.102496
BibTeX
@article{Nahlkov2024,
author = {Nahálková, Jarmila},
title = {On the interface of aging, cancer, and neurodegeneration with SIRT6 and L1 retrotransposon protein interaction network},
journal = {Ageing Research Reviews},
year = {2024},
doi = {10.1016/j.arr.2024.102496}
}
EUVIMED